Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 83, Issue 7, 2012, Pages 687-694

  Stout, Julie C ^a   Jones, Rebecca ^b   Labuschagne, Izelle ^a   O'Regan, Alison M ^a   Say, Miranda J ^c   Dumas, Eve M ^d   Queller, Sarah ^a,e   Justo, Damian ^f   Dar Santos, Rachelle ^g   Coleman, Allison ^g   Hart, Ellen P ^d   Dürr, Alexandra ^f   Leavitt, Blair R ^g   Roos, Raymund A ^d   Langbehn, Doug R ^h   Tabrizi, Sarah J ^c   Frost, Chris ^b  

^a MONASH UNIVERSITY   (Australia)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e Queller Consulting   (United States)

^f INSERM   (France)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^h UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN CORTEX; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE COURSE; FEMALE; HUMAN; HUNTINGTON CHOREA; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; COGNITION DISORDERS; DISEASE PROGRESSION; FEMALE; HUMANS; HUNTINGTON DISEASE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84861843888     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2011-301940     Document Type: Article

References (16)

1. Gómez-Tortosa E, MacDonald ME, Friend JC, et al. Quantitative neuropathological changes in presymptomatic Huntington's disease. Ann Neurol 2001;49:29-34. (Pubitemid 32163003)
2. Gusella JF, McNeil S, Persichetti F, et al. Huntington's disease. Cold Spring Harb Symp Quant Biol 1996;61:615-26. (Pubitemid 27258008)
3. Tabrizi SJ, Scahill RI, Durr A, et al. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol 2011;10:31-42.
4. Tabrizi SJ, Reilmann R, Roos RA, et al. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data. Lancet Neurol 2012;11:42-53.
5. Tabrizi SJ, Langbehn DR, Leavitt BR, et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 2009;8:791-801.
6. Penney JB, Vonsattel JP, MacDonald ME, et al. CAG repeat number governs the development rate of pathology in Huntington's disease. Ann Neurol 1997;41:689-92. (Pubitemid 27212666)
7. Huntington study group. Unified Huntington's disease rating Scale-99. Rochester, NY: Huntington Study Group, 1999.
8. UNESCO. International Standard Classification of Education. 1997. http://www.uis. unesco.org (accessed 16 Nov 2007).
9. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New York, USA: Chapman &Hall, 1993.
10. Altman DG. Practical Statistics for Medical Research. London, UK: Chapman and Hall, 1991.
11. Bachoud-Levi AC, Maison P, Bartolomeo P, et al. Retest effects and cognitive decline in longitudinal follow-up of patients with early HD. Neurology 2001;56:1052-8. (Pubitemid 32336313)
12. Beglinger LJ, Duff K, Allison J, et al. Cognitive change in patients with Huntington disease on the repeatable battery of the assessment of neuropsychological status. J Clin Exp Neuropsychol 2010;32:573-8.
13. Lemiere J, Decruyenaere M, Evers-Kiebooms G, et al. Longitudinal study evaluating neuropsychological changes in so-called asymptomatic carriers of the Huntington's disease mutation after 1 year. Acta Neurol Scand 2002;106:131-41.
14. Saleh N, Moutereau S, Azulay JP, et al. High insulin-like growth factor I is associated with cognitive decline in Huntington disease. Neurology 2010;75:57-63.
15. Witjes-Ane MN, Mertens B, van Vugt JP, et al. Longitudinal evaluation of "presymptomatic" carriers of Huntington's disease. J Neuropsychiatry Clin Neurosci 2007;19:310-17. (Pubitemid 47293905)
16. Stout JC, Paulsen J, Queller S, et al. Neurocognitive signs in prodromal Huntington disease. Neuropsychology 2011;25:1-14.